Literature DB >> 28429660

Risk of abdominal aortic aneurysm (AAA) among male and female relatives of AAA patients.

Koen M van de Luijtgaarden1, Ellen V Rouwet1, Sanne E Hoeks2, Robert J Stolker2, Hence Jm Verhagen1, Danielle Majoor-Krakauer3.   

Abstract

Sex affects the presentation, treatment, and outcomes of abdominal aortic aneurysm (AAA). Although AAAs are less prevalent in women, at least in the general population, women with an AAA have a poorer prognosis in comparison to men. Sex differences in the genetic predisposition for aneurysm disease remain to be established. In this study we investigated the familial risk of AAA for women compared to men. All living AAA patients included in a 2004-2012 prospective database were invited to the multidisciplinary vascular/genetics outpatient clinic between 2009 and 2012 for assessment of family history using detailed questionnaires. AAA risk for male and female relatives was calculated separately and stratified by sex of the AAA patients. Families of 568 AAA patients were investigated and 22.5% of the patients had at least one affected relative. Female relatives had a 2.8-fold and male relatives had a 1.7-fold higher risk than the estimated sex-specific population risk. Relatives of female AAA patients had a higher aneurysm risk than relatives of male patients (9.0 vs 5.9%, p = 0.022), corresponding to 5.5- and 2.0-fold increases in aneurysm risk in the female and male relatives, respectively. The risk for aortic aneurysm in relatives of AAA patients is higher than expected from population risk. The excess risk is highest for the female relatives of AAA patients and for the relatives of female AAA patients. These findings endorse targeted AAA family screening for female and male relatives of all AAA patients.

Entities:  

Keywords:  abdominal aortic aneurysm (AAA); aneurysm screening; family history; family screening; genetics; risk factors; sex differences

Mesh:

Year:  2017        PMID: 28429660     DOI: 10.1177/1358863X16686409

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  6 in total

1.  Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice.

Authors:  Zhu Wang; Jingjing Guo; Xinqiang Han; Ming Xue; Wenming Wang; Lei Mi; Yuguo Sheng; Chao Ma; Jian Wu; Xuejun Wu
Journal:  Cell Biosci       Date:  2019-08-27       Impact factor: 7.133

2.  Image-Based 3D Characterization of Abdominal Aortic Aneurysm Deformation After Endovascular Aneurysm Repair.

Authors:  Karen López-Linares; Inmaculada García; Ainhoa García; Camilo Cortes; Gemma Piella; Iván Macía; Jérôme Noailly; Miguel A González Ballester
Journal:  Front Bioeng Biotechnol       Date:  2019-11-01

3.  Inflammation and TGF-β Signaling Differ between Abdominal Aneurysms and Occlusive Disease.

Authors:  A IJpma; L Te Riet; K M van de Luijtgaarden; P M van Heijningen; J Burger; D Majoor-Krakauer; E V Rouwet; J Essers; H J M Verhagen; I van der Pluijm
Journal:  J Cardiovasc Dev Dis       Date:  2019-11-01

4.  Polygenic Susceptibility of Aortic Aneurysms Associates to the Diameter of the Aneurysm Sac: the Aneurysm-Express Biobank Cohort.

Authors:  Constance J H C M van Laarhoven; Jessica van Setten; Joost A van Herwaarden; Gerard Pasterkamp; Dominique P V de Kleijn; Gert J de Borst; Sander W van der Laan
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 5.  Fibrates: A Possible Treatment Option for Patients with Abdominal Aortic Aneurysm?

Authors:  Naofumi Amioka; Toru Miyoshi
Journal:  Biomolecules       Date:  2022-01-05

6.  Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression.

Authors:  Gabor Gäbel; Bernd H Northoff; Amanda Balboa; Mediha Becirovic-Agic; Marcelo Petri; Albert Busch; Lars Maegdefessel; Adrian Mahlmann; Stefan Ludwig; Daniel Teupser; Vivian de Waard; Jonathan Golledge; Anders Wanhainen; Dick Wågsäter; Lesca M Holdt; Jan H N Lindeman
Journal:  J Am Heart Assoc       Date:  2021-08-21       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.